TRCSX
Price
$20.50
Change
-$0.10 (-0.49%)
Updated
Jul 31 closing price
Net Assets
478.73M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

TRCSX vs VSCIX

TRCSX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
TRCSX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRCSX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. TRCSX (479M). VSCIX pays higher dividends than TRCSX: VSCIX (1.23) vs TRCSX (1.06). TRCSX was incepted earlier than VSCIX: TRCSX (11 years) vs VSCIX (29 years). TRCSX (0.26) is less costly to investors than VSCIX (0.03). TRCSX is a more actively managed with annual turnover of: 19.90 vs. VSCIX (17.00). TRCSX has a lower initial minimum investment than VSCIX: TRCSX (500000) vs VSCIX (5000000). TRCSX annual gain was more profitable for investors over the last year : 32.76 vs. VSCIX (22.58). TRCSX (35.60) and VSCIX (35.13) have equivalent 5 years return.
TRCSXVSCIXTRCSX / VSCIX
Total Expense Ratio0.140.03467%
Annual Report Gross Expense Ratio0.260.03867%
Fund Existence11 years29 years-
Gain YTD18.91014.591130%
Front LoadN/AN/A-
Min. Initial Investment500000500000010%
Min. Initial Investment IRAN/AN/A-
Net Assets479M189B0%
Annual Yield % from dividends1.061.2387%
Returns for 1 year32.7622.58145%
Returns for 3 years48.9243.44113%
Returns for 5 years35.6035.13101%
Returns for 10 years117.35156.0775%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C